Trials / Unknown
UnknownNCT02614352
Investigate a Pharmacokinetic Characteristics and the Safety of AG1502 in Healthy Male Subjects
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Ahn-Gook Pharmaceuticals Co.,Ltd · Industry
- Sex
- Male
- Age
- 19 Years – 45 Years
- Healthy volunteers
- —
Summary
Primary object : Evaluate pharmacokinetic property AG1502 and Candesartan 32mg and Atorvastatin 40mg in healthy male subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Atorvastatin + Candesartan | |
| DRUG | AG1502 |
Timeline
- Primary completion
- 2016-02-01
- First posted
- 2015-11-25
- Last updated
- 2015-11-25
Source: ClinicalTrials.gov record NCT02614352. Inclusion in this directory is not an endorsement.